theophylline has been researched along with baicalein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
| Guo, P; Li, N; Li, W; Liu, Z; Ma, X; Pi, J; Qi, D; Wang, S; Zhang, B; Zhang, Y | 1 |
2 other study(ies) available for theophylline and baicalein
| Article | Year |
|---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
A strategy to improve the oral availability of baicalein: The baicalein-theophylline cocrystal.
Topics: Administration, Oral; Animals; Biological Availability; Calorimetry, Differential Scanning; Crystallization; Flavanones; Rats; Rats, Sprague-Dawley; Solubility; Theophylline; X-Ray Diffraction | 2018 |